Share Price and Basic Stock Data
Last Updated: November 3, 2025, 11:09 pm
| PEG Ratio | -13.23 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Bhagiradha Chemicals & Industries Ltd operates within the agro-chemicals sector, focusing on the production and distribution of pesticides. The company reported a market capitalization of ₹3,275 Cr and a stock price of ₹253. Over recent years, the revenue trajectory has shown fluctuations, with sales reaching ₹502 Cr in FY 2023, marking an increase from ₹436 Cr in FY 2022. However, projections for FY 2024 indicate a decline in sales to ₹407 Cr, followed by a rebound to ₹436 Cr in FY 2025. The quarterly sales data for Jun 2023 was ₹100.01 Cr, a significant drop from ₹122.57 Cr in Mar 2023, reflecting a challenging market environment. This volatility underscores the company’s sensitivity to market conditions, possibly affecting its operational stability and growth potential.
Profitability and Efficiency Metrics
Profitability metrics for Bhagiradha Chemicals exhibit a mixed performance. The operating profit margin (OPM) stood at 8.08% as of FY 2025, down from a high of 16% in FY 2022, indicating pressure on margins. The net profit for FY 2025 was reported at ₹27 Cr, a decline from ₹36 Cr in FY 2022, which translates to a net profit margin of 3.14%. The interest coverage ratio (ICR) was solid at 6.50x, suggesting that the company can comfortably meet its interest obligations. However, the return on equity (ROE) was relatively low at 4.91%, indicating that shareholder returns may not be maximized. With a cash conversion cycle of 169 days, the company faces challenges in managing its working capital efficiently, which may further impact profitability.
Balance Sheet Strength and Financial Ratios
Bhagiradha Chemicals has demonstrated a cautious approach to leverage, with total borrowings reported at ₹77 Cr against reserves of ₹686 Cr. This positions the company with a debt-to-equity ratio of 0.12x, indicating a low reliance on debt financing. The current ratio stood at 1.92, reflecting adequate liquidity to cover short-term obligations. Additionally, the price-to-book value (P/BV) ratio was 5.28x, which is high compared to typical sector benchmarks, suggesting that the stock may be overvalued relative to its book value. The company’s asset turnover ratio of 0.58% indicates less efficient use of assets to generate revenue, which could be a concern for investors. Overall, while the balance sheet shows resilience, the high P/BV ratio and asset turnover concerns warrant attention.
Shareholding Pattern and Investor Confidence
The shareholding structure of Bhagiradha Chemicals reveals a predominant public holding of 77.48%, indicating broad retail investor participation. Promoter holdings have seen a decline from 23.52% in Dec 2022 to 19.60% by Sep 2025, which may raise concerns regarding insider confidence in the company’s future prospects. Foreign institutional investors (FIIs) hold a minimal 0.05%, while domestic institutional investors (DIIs) account for 2.89%. The increasing number of shareholders, which rose to 13,761 by Sep 2025 from 3,465 in Dec 2022, suggests growing retail interest, potentially driven by the company’s visibility in the agro-chemicals market. However, the low institutional investment may reflect caution among larger investors regarding the company’s future growth and profitability trajectory.
Outlook, Risks, and Final Insight
Looking ahead, Bhagiradha Chemicals faces both opportunities and challenges. The recovery in sales to ₹436 Cr in FY 2025 presents a potential uplift, yet the decline in profit margins and ROE indicates ongoing operational pressures. Key strengths include a solid interest coverage ratio and manageable debt levels, positioning the company well for debt servicing. However, risks such as high inventory turnover days, low institutional investment, and declining promoter holdings could hinder investor confidence. The company must focus on operational efficiencies and margin improvement to enhance profitability. In scenarios where the market stabilizes and operational efficiencies are realized, Bhagiradha Chemicals could see improved financial health; conversely, continued market volatility and operational challenges may impede growth prospects.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bhagiradha Chemicals & Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 7,315 Cr. | 1,698 | 2,243/1,502 | 17.0 | 441 | 0.35 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 893 Cr. | 265 | 391/165 | 17.1 | 117 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 55.8 Cr. | 107 | 148/55.2 | 10.2 | 34.1 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,222 Cr. | 248 | 392/228 | 113 | 53.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 775 Cr. | 327 | 670/244 | 11.3 | 320 | 0.92 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,553.15 Cr | 1,544.66 | 34.13 | 441.55 | 0.42% | 15.21% | 19.87% | 7.25 |
All Competitor Stocks of Bhagiradha Chemicals & Industries Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 121.72 | 131.81 | 126.00 | 122.57 | 100.01 | 122.01 | 74.37 | 110.32 | 110.78 | 100.22 | 102.73 | 122.63 | 123.78 |
| Expenses | 102.10 | 111.47 | 106.39 | 104.28 | 92.80 | 108.45 | 66.19 | 96.37 | 98.94 | 90.47 | 93.43 | 115.39 | 113.78 |
| Operating Profit | 19.62 | 20.34 | 19.61 | 18.29 | 7.21 | 13.56 | 8.18 | 13.95 | 11.84 | 9.75 | 9.30 | 7.24 | 10.00 |
| OPM % | 16.12% | 15.43% | 15.56% | 14.92% | 7.21% | 11.11% | 11.00% | 12.65% | 10.69% | 9.73% | 9.05% | 5.90% | 8.08% |
| Other Income | 0.20 | 0.51 | 0.62 | 0.51 | 0.42 | 0.48 | 1.38 | 2.53 | 3.64 | 5.24 | 5.50 | 6.10 | 3.50 |
| Interest | 1.77 | 0.82 | 0.84 | 1.55 | 1.72 | 2.26 | 1.57 | 2.14 | 1.34 | 1.65 | 2.29 | 1.36 | 2.93 |
| Depreciation | 2.30 | 2.40 | 2.45 | 2.51 | 2.61 | 2.70 | 2.82 | 2.83 | 2.82 | 2.91 | 3.11 | 3.10 | 3.36 |
| Profit before tax | 15.75 | 17.63 | 16.94 | 14.74 | 3.30 | 9.08 | 5.17 | 11.51 | 11.32 | 10.43 | 9.40 | 8.88 | 7.21 |
| Tax % | 23.94% | 28.93% | 28.57% | 33.38% | 33.33% | 30.62% | 28.63% | 29.37% | 36.13% | 24.45% | 24.15% | 41.89% | -14.84% |
| Net Profit | 11.98 | 12.52 | 12.09 | 9.82 | 2.20 | 6.29 | 3.69 | 8.12 | 7.23 | 7.87 | 7.13 | 5.16 | 8.29 |
| EPS in Rs | 1.15 | 1.20 | 1.16 | 0.94 | 0.21 | 0.60 | 0.35 | 0.78 | 0.58 | 0.63 | 0.57 | 0.40 | 0.64 |
Last Updated: August 19, 2025, 10:20 pm
Below is a detailed analysis of the quarterly data for Bhagiradha Chemicals & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 123.78 Cr.. The value appears strong and on an upward trend. It has increased from 122.63 Cr. (Mar 2025) to 123.78 Cr., marking an increase of 1.15 Cr..
- For Expenses, as of Jun 2025, the value is 113.78 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 115.39 Cr. (Mar 2025) to 113.78 Cr., marking a decrease of 1.61 Cr..
- For Operating Profit, as of Jun 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.24 Cr. (Mar 2025) to 10.00 Cr., marking an increase of 2.76 Cr..
- For OPM %, as of Jun 2025, the value is 8.08%. The value appears strong and on an upward trend. It has increased from 5.90% (Mar 2025) to 8.08%, marking an increase of 2.18%.
- For Other Income, as of Jun 2025, the value is 3.50 Cr.. The value appears to be declining and may need further review. It has decreased from 6.10 Cr. (Mar 2025) to 3.50 Cr., marking a decrease of 2.60 Cr..
- For Interest, as of Jun 2025, the value is 2.93 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.36 Cr. (Mar 2025) to 2.93 Cr., marking an increase of 1.57 Cr..
- For Depreciation, as of Jun 2025, the value is 3.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.10 Cr. (Mar 2025) to 3.36 Cr., marking an increase of 0.26 Cr..
- For Profit before tax, as of Jun 2025, the value is 7.21 Cr.. The value appears to be declining and may need further review. It has decreased from 8.88 Cr. (Mar 2025) to 7.21 Cr., marking a decrease of 1.67 Cr..
- For Tax %, as of Jun 2025, the value is -14.84%. The value appears to be improving (decreasing) as expected. It has decreased from 41.89% (Mar 2025) to -14.84%, marking a decrease of 56.73%.
- For Net Profit, as of Jun 2025, the value is 8.29 Cr.. The value appears strong and on an upward trend. It has increased from 5.16 Cr. (Mar 2025) to 8.29 Cr., marking an increase of 3.13 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.64. The value appears strong and on an upward trend. It has increased from 0.40 (Mar 2025) to 0.64, marking an increase of 0.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:47 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 174 | 220 | 152 | 203 | 183 | 384 | 246 | 318 | 436 | 502 | 407 | 436 | 449 |
| Expenses | 164 | 209 | 148 | 191 | 172 | 343 | 229 | 271 | 367 | 424 | 364 | 398 | 413 |
| Operating Profit | 11 | 11 | 4 | 11 | 12 | 41 | 17 | 47 | 68 | 78 | 43 | 38 | 36 |
| OPM % | 6% | 5% | 3% | 6% | 6% | 11% | 7% | 15% | 16% | 16% | 11% | 9% | 8% |
| Other Income | 1 | 1 | 1 | 2 | -8 | 1 | 4 | 2 | 1 | 2 | 5 | 20 | 20 |
| Interest | 4 | 6 | 7 | 7 | 7 | 8 | 5 | 8 | 9 | 5 | 8 | 7 | 8 |
| Depreciation | 5 | 3 | 4 | 4 | 3 | 5 | 7 | 8 | 9 | 10 | 11 | 12 | 12 |
| Profit before tax | 2 | 3 | -5 | 3 | -6 | 29 | 9 | 32 | 51 | 65 | 29 | 40 | 36 |
| Tax % | 10% | 17% | -39% | 61% | -77% | 37% | 27% | 27% | 30% | 29% | 30% | 32% | |
| Net Profit | 2 | 3 | -3 | 1 | -1 | 18 | 7 | 23 | 36 | 46 | 20 | 27 | 28 |
| EPS in Rs | 0.31 | 0.40 | -0.51 | 0.16 | -0.14 | 1.78 | 0.63 | 2.28 | 3.50 | 4.46 | 1.95 | 2.11 | 2.24 |
| Dividend Payout % | 26% | 20% | 0% | 0% | 0% | 9% | 0% | 0% | 7% | 9% | 5% | 7% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 50.00% | -200.00% | 133.33% | -200.00% | 1900.00% | -61.11% | 228.57% | 56.52% | 27.78% | -56.52% | 35.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -250.00% | 333.33% | -333.33% | 2100.00% | -1961.11% | 289.68% | -172.05% | -28.74% | -84.30% | 91.52% |
Bhagiradha Chemicals & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 12% |
| 3 Years: | 0% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 40% |
| 3 Years: | -9% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 43% |
| 5 Years: | 56% |
| 3 Years: | 27% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 8% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: August 11, 2025, 3:29 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 8 | 8 | 8 | 8 | 8 | 10 | 10 | 13 |
| Reserves | 43 | 44 | 41 | 46 | 94 | 120 | 124 | 148 | 182 | 304 | 407 | 686 |
| Borrowings | 53 | 71 | 62 | 64 | 61 | 47 | 43 | 62 | 81 | 50 | 61 | 77 |
| Other Liabilities | 41 | 75 | 71 | 91 | 80 | 98 | 50 | 55 | 71 | 82 | 89 | 138 |
| Total Liabilities | 142 | 195 | 179 | 206 | 243 | 274 | 225 | 273 | 342 | 446 | 568 | 914 |
| Fixed Assets | 48 | 52 | 66 | 69 | 77 | 106 | 138 | 145 | 149 | 164 | 176 | 203 |
| CWIP | 9 | 16 | 0 | 0 | 0 | 4 | 4 | 1 | 3 | 6 | 5 | 15 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 9 | 42 | 80 | 42 |
| Other Assets | 85 | 127 | 113 | 138 | 166 | 164 | 83 | 119 | 181 | 234 | 306 | 654 |
| Total Assets | 142 | 195 | 179 | 206 | 243 | 274 | 225 | 273 | 342 | 446 | 568 | 914 |
Below is a detailed analysis of the balance sheet data for Bhagiradha Chemicals & Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 3.00 Cr..
- For Reserves, as of Mar 2025, the value is 686.00 Cr.. The value appears strong and on an upward trend. It has increased from 407.00 Cr. (Mar 2024) to 686.00 Cr., marking an increase of 279.00 Cr..
- For Borrowings, as of Mar 2025, the value is 77.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 61.00 Cr. (Mar 2024) to 77.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 138.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 89.00 Cr. (Mar 2024) to 138.00 Cr., marking an increase of 49.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 914.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 568.00 Cr. (Mar 2024) to 914.00 Cr., marking an increase of 346.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 203.00 Cr.. The value appears strong and on an upward trend. It has increased from 176.00 Cr. (Mar 2024) to 203.00 Cr., marking an increase of 27.00 Cr..
- For CWIP, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 10.00 Cr..
- For Investments, as of Mar 2025, the value is 42.00 Cr.. The value appears to be declining and may need further review. It has decreased from 80.00 Cr. (Mar 2024) to 42.00 Cr., marking a decrease of 38.00 Cr..
- For Other Assets, as of Mar 2025, the value is 654.00 Cr.. The value appears strong and on an upward trend. It has increased from 306.00 Cr. (Mar 2024) to 654.00 Cr., marking an increase of 348.00 Cr..
- For Total Assets, as of Mar 2025, the value is 914.00 Cr.. The value appears strong and on an upward trend. It has increased from 568.00 Cr. (Mar 2024) to 914.00 Cr., marking an increase of 346.00 Cr..
Notably, the Reserves (686.00 Cr.) exceed the Borrowings (77.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -42.00 | -60.00 | -58.00 | -53.00 | -49.00 | -6.00 | -26.00 | -15.00 | -13.00 | 28.00 | -18.00 | -39.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 82 | 67 | 31 | 71 | 80 | 17 | 68 | 81 | 94 | 95 | 145 |
| Inventory Days | 99 | 139 | 256 | 282 | 281 | 77 | 137 | 97 | 91 | 108 | 166 | 158 |
| Days Payable | 104 | 143 | 216 | 205 | 191 | 110 | 59 | 89 | 73 | 69 | 95 | 135 |
| Cash Conversion Cycle | 66 | 78 | 106 | 108 | 161 | 47 | 95 | 76 | 99 | 132 | 167 | 169 |
| Working Capital Days | 4 | -0 | -19 | -21 | 49 | 16 | -12 | 21 | 32 | 91 | 120 | 395 |
| ROCE % | 7% | 8% | 0% | 8% | 7% | 22% | 7% | 20% | 25% | 22% | 9% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.14 | 17.51 | 44.35 | 43.02 | 28.06 |
| Diluted EPS (Rs.) | 1.14 | 16.10 | 44.35 | 43.02 | 28.06 |
| Cash EPS (Rs.) | 2.14 | 28.06 | 52.82 | 53.37 | 37.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 52.61 | 397.59 | 301.04 | 227.82 | 186.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 52.61 | 397.59 | 301.04 | 227.82 | 186.80 |
| Revenue From Operations / Share (Rs.) | 33.97 | 391.76 | 482.52 | 522.74 | 381.44 |
| PBDIT / Share (Rs.) | 3.56 | 43.81 | 75.52 | 82.94 | 57.02 |
| PBIT / Share (Rs.) | 2.50 | 33.26 | 66.10 | 72.47 | 47.22 |
| PBT / Share (Rs.) | 1.95 | 25.87 | 61.30 | 61.56 | 38.57 |
| Net Profit / Share (Rs.) | 1.07 | 17.51 | 43.39 | 42.89 | 27.98 |
| NP After MI And SOA / Share (Rs.) | 1.07 | 17.51 | 43.39 | 42.89 | 27.98 |
| PBDIT Margin (%) | 10.49 | 11.18 | 15.65 | 15.86 | 14.94 |
| PBIT Margin (%) | 7.34 | 8.49 | 13.69 | 13.86 | 12.38 |
| PBT Margin (%) | 5.73 | 6.60 | 12.70 | 11.77 | 10.11 |
| Net Profit Margin (%) | 3.14 | 4.46 | 8.99 | 8.20 | 7.33 |
| NP After MI And SOA Margin (%) | 3.14 | 4.46 | 8.99 | 8.20 | 7.33 |
| Return on Networth / Equity (%) | 2.03 | 4.40 | 14.41 | 18.82 | 14.97 |
| Return on Capital Employeed (%) | 4.38 | 7.68 | 19.86 | 28.84 | 22.10 |
| Return On Assets (%) | 1.48 | 3.16 | 10.10 | 10.45 | 8.53 |
| Long Term Debt / Equity (X) | 0.04 | 0.04 | 0.05 | 0.05 | 0.12 |
| Total Debt / Equity (X) | 0.12 | 0.14 | 0.15 | 0.42 | 0.37 |
| Asset Turnover Ratio (%) | 0.58 | 0.79 | 1.27 | 1.42 | 1.28 |
| Current Ratio (X) | 1.92 | 2.23 | 2.27 | 1.31 | 1.20 |
| Quick Ratio (X) | 1.26 | 1.34 | 1.36 | 0.79 | 0.66 |
| Inventory Turnover Ratio (X) | 3.65 | 2.69 | 4.23 | 4.66 | 3.68 |
| Dividend Payout Ratio (NP) (%) | 8.97 | 17.13 | 6.91 | 2.32 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 4.48 | 10.68 | 5.67 | 1.86 | 0.00 |
| Earning Retention Ratio (%) | 91.03 | 82.87 | 93.09 | 97.68 | 0.00 |
| Cash Earning Retention Ratio (%) | 95.52 | 89.32 | 94.33 | 98.14 | 0.00 |
| Interest Coverage Ratio (X) | 6.50 | 5.93 | 15.74 | 7.61 | 5.75 |
| Interest Coverage Ratio (Post Tax) (X) | 2.95 | 3.37 | 10.04 | 4.93 | 3.69 |
| Enterprise Value (Cr.) | 3659.46 | 1726.83 | 1291.27 | 923.65 | 478.11 |
| EV / Net Operating Revenue (X) | 8.31 | 4.24 | 2.57 | 2.12 | 1.50 |
| EV / EBITDA (X) | 79.16 | 37.88 | 16.43 | 13.36 | 10.06 |
| MarketCap / Net Operating Revenue (X) | 8.18 | 4.11 | 2.48 | 1.94 | 1.32 |
| Retention Ratios (%) | 91.02 | 82.86 | 93.08 | 97.67 | 0.00 |
| Price / BV (X) | 5.28 | 4.05 | 3.98 | 4.46 | 2.70 |
| Price / Net Operating Revenue (X) | 8.18 | 4.11 | 2.48 | 1.94 | 1.32 |
| EarningsYield | 0.00 | 0.01 | 0.03 | 0.04 | 0.05 |
After reviewing the key financial ratios for Bhagiradha Chemicals & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 17.51 (Mar 24) to 1.14, marking a decrease of 16.37.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 5. It has decreased from 16.10 (Mar 24) to 1.14, marking a decrease of 14.96.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 3. It has decreased from 28.06 (Mar 24) to 2.14, marking a decrease of 25.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.61. It has decreased from 397.59 (Mar 24) to 52.61, marking a decrease of 344.98.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 52.61. It has decreased from 397.59 (Mar 24) to 52.61, marking a decrease of 344.98.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 33.97. It has decreased from 391.76 (Mar 24) to 33.97, marking a decrease of 357.79.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.56. This value is within the healthy range. It has decreased from 43.81 (Mar 24) to 3.56, marking a decrease of 40.25.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.50. This value is within the healthy range. It has decreased from 33.26 (Mar 24) to 2.50, marking a decrease of 30.76.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 25.87 (Mar 24) to 1.95, marking a decrease of 23.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 17.51 (Mar 24) to 1.07, marking a decrease of 16.44.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.07. This value is below the healthy minimum of 2. It has decreased from 17.51 (Mar 24) to 1.07, marking a decrease of 16.44.
- For PBDIT Margin (%), as of Mar 25, the value is 10.49. This value is within the healthy range. It has decreased from 11.18 (Mar 24) to 10.49, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 7.34. This value is below the healthy minimum of 10. It has decreased from 8.49 (Mar 24) to 7.34, marking a decrease of 1.15.
- For PBT Margin (%), as of Mar 25, the value is 5.73. This value is below the healthy minimum of 10. It has decreased from 6.60 (Mar 24) to 5.73, marking a decrease of 0.87.
- For Net Profit Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 5. It has decreased from 4.46 (Mar 24) to 3.14, marking a decrease of 1.32.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 8. It has decreased from 4.46 (Mar 24) to 3.14, marking a decrease of 1.32.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 15. It has decreased from 4.40 (Mar 24) to 2.03, marking a decrease of 2.37.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 10. It has decreased from 7.68 (Mar 24) to 4.38, marking a decrease of 3.30.
- For Return On Assets (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 5. It has decreased from 3.16 (Mar 24) to 1.48, marking a decrease of 1.68.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. It has decreased from 0.14 (Mar 24) to 0.12, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.58. It has decreased from 0.79 (Mar 24) to 0.58, marking a decrease of 0.21.
- For Current Ratio (X), as of Mar 25, the value is 1.92. This value is within the healthy range. It has decreased from 2.23 (Mar 24) to 1.92, marking a decrease of 0.31.
- For Quick Ratio (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.26, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 4. It has increased from 2.69 (Mar 24) to 3.65, marking an increase of 0.96.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 20. It has decreased from 17.13 (Mar 24) to 8.97, marking a decrease of 8.16.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 20. It has decreased from 10.68 (Mar 24) to 4.48, marking a decrease of 6.20.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.03. This value exceeds the healthy maximum of 70. It has increased from 82.87 (Mar 24) to 91.03, marking an increase of 8.16.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 95.52. This value exceeds the healthy maximum of 70. It has increased from 89.32 (Mar 24) to 95.52, marking an increase of 6.20.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.50. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 6.50, marking an increase of 0.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has decreased from 3.37 (Mar 24) to 2.95, marking a decrease of 0.42.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,659.46. It has increased from 1,726.83 (Mar 24) to 3,659.46, marking an increase of 1,932.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.31. This value exceeds the healthy maximum of 3. It has increased from 4.24 (Mar 24) to 8.31, marking an increase of 4.07.
- For EV / EBITDA (X), as of Mar 25, the value is 79.16. This value exceeds the healthy maximum of 15. It has increased from 37.88 (Mar 24) to 79.16, marking an increase of 41.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 8.18, marking an increase of 4.07.
- For Retention Ratios (%), as of Mar 25, the value is 91.02. This value exceeds the healthy maximum of 70. It has increased from 82.86 (Mar 24) to 91.02, marking an increase of 8.16.
- For Price / BV (X), as of Mar 25, the value is 5.28. This value exceeds the healthy maximum of 3. It has increased from 4.05 (Mar 24) to 5.28, marking an increase of 1.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has increased from 4.11 (Mar 24) to 8.18, marking an increase of 4.07.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bhagiradha Chemicals & Industries Ltd:
- Net Profit Margin: 3.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.38% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.03% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.95
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.26
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 113 (Industry average Stock P/E: 34.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.12
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.14%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | Unit No.1011A, Level 1, Sky One (Wing A), Hyderabad Telangana 500032 | info@bhagirad.com http://www.bhagirad.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kishor Shah | Chairman(NonExe.&Ind.Director) |
| Mr. Chandra Sekhar Singavarapu | Managing Director |
| Mr. Arvind Kumar Anegondi | Executive Director & CEO |
| Mr. Krishna Rao S V Gadepalli | Ind. Non-Executive Director |
| Dr. G Aruna | Ind. Non-Executive Woman Director |
| Mr. Suresh Kumar Somani | Non Exe.Non Ind.Director |
| Mrs. Lalitha Sree Singavarapu | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Bhagiradha Chemicals & Industries Ltd?
Bhagiradha Chemicals & Industries Ltd's intrinsic value (as of 03 November 2025) is 239.39 which is 3.47% lower the current market price of 248.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,222 Cr. market cap, FY2025-2026 high/low of 392/228, reserves of ₹686 Cr, and liabilities of 914 Cr.
What is the Market Cap of Bhagiradha Chemicals & Industries Ltd?
The Market Cap of Bhagiradha Chemicals & Industries Ltd is 3,222 Cr..
What is the current Stock Price of Bhagiradha Chemicals & Industries Ltd as on 03 November 2025?
The current stock price of Bhagiradha Chemicals & Industries Ltd as on 03 November 2025 is 248.
What is the High / Low of Bhagiradha Chemicals & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bhagiradha Chemicals & Industries Ltd stocks is 392/228.
What is the Stock P/E of Bhagiradha Chemicals & Industries Ltd?
The Stock P/E of Bhagiradha Chemicals & Industries Ltd is 113.
What is the Book Value of Bhagiradha Chemicals & Industries Ltd?
The Book Value of Bhagiradha Chemicals & Industries Ltd is 53.9.
What is the Dividend Yield of Bhagiradha Chemicals & Industries Ltd?
The Dividend Yield of Bhagiradha Chemicals & Industries Ltd is 0.06 %.
What is the ROCE of Bhagiradha Chemicals & Industries Ltd?
The ROCE of Bhagiradha Chemicals & Industries Ltd is 7.44 %.
What is the ROE of Bhagiradha Chemicals & Industries Ltd?
The ROE of Bhagiradha Chemicals & Industries Ltd is 4.91 %.
What is the Face Value of Bhagiradha Chemicals & Industries Ltd?
The Face Value of Bhagiradha Chemicals & Industries Ltd is 1.00.